Begin typing your search...
AstraZeneca Pharma India Q3 net profit declines 21 pc at Rs 21 cr
Drug firm AstraZeneca Pharma India on Monday reported a 21 per cent decline in net profit at Rs 21.05 crore for the quarter ended in December.
By
migrator
migrator
New Delhi
The company had posted a net profit of Rs 26.70 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a BSE filing.Â
Revenue from operations of the company stood at Rs 200.25 crore for the quarter under consideration. It was Rs 223.86 crore for the same period a year ago, it added.Â
Shares of AstraZeneca Pharma India closed at Rs 3,899.40 per scrip on BSE, up 0.11 percent from its previous close.
Visit news.dtnext.in to explore our interactive epaper!
Download the DT Next app for more exciting features!
Click here for iOS
Click here for Android
Next Story
